(R)-1-(4-((1-(benzo[d][1,3]dioxol-5-ylmethyl)pyrrolidin-2-yl)methoxy)phenyl)-1H-imidazole

ID: ALA388881

PubChem CID: 44430567

Max Phase: Preclinical

Molecular Formula: C22H23N3O3

Molecular Weight: 377.44

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  c1cn(-c2ccc(OC[C@H]3CCCN3Cc3ccc4c(c3)OCO4)cc2)cn1

Standard InChI:  InChI=1S/C22H23N3O3/c1-2-19(14-26-20-6-4-18(5-7-20)25-11-9-23-15-25)24(10-1)13-17-3-8-21-22(12-17)28-16-27-21/h3-9,11-12,15,19H,1-2,10,13-14,16H2/t19-/m1/s1

Standard InChI Key:  LJMQPVKSZNDSKH-LJQANCHMSA-N

Molfile:  

     RDKit          2D

 28 32  0  0  1  0  0  0  0  0999 V2000
   -2.1586  -23.5027    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4422  -23.0894    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4450  -22.2588    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1604  -21.8497    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8734  -23.0898    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8768  -22.2655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6618  -22.0139    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1436  -22.6828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6564  -23.3477    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7321  -21.8436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7352  -21.0186    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0621  -20.5346    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3141  -19.7532    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1454  -19.7531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3983  -20.5368    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7220  -20.7911    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3362  -20.2403    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1203  -20.4968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2880  -21.3047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0713  -21.5613    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6865  -21.0102    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5131  -20.1993    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7300  -19.9465    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4709  -21.2657    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.7286  -22.0493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5536  -22.0499    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.8091  -21.2653    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1420  -20.7801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 11  1  0
  3  4  2  0
 12 16  1  6
  6  7  1  0
 16 17  1  0
  7  8  1  0
 17 18  1  0
  8  9  1  0
 18 19  2  0
  9  5  1  0
 19 20  1  0
  4  6  1  0
 20 21  2  0
  3 10  1  0
 21 22  1  0
  5  6  2  0
 22 23  2  0
 23 18  1  0
 10 11  1  0
 21 24  1  0
 24 25  1  0
 11 12  1  0
  1  2  2  0
  5  1  1  0
  2  3  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 24  1  0
M  END

Associated Targets(Human)

A 172 (535 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NOS2 Tchem Nitric oxide synthase, inducible (1636 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NOS1 Tchem Nitric oxide sythases; iNOS & nNOS (685 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 377.44Molecular Weight (Monoisotopic): 377.1739AlogP: 3.64#Rotatable Bonds: 6
Polar Surface Area: 48.75Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.42CX LogP: 3.41CX LogD: 2.34
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.66Np Likeness Score: -1.32

References

1. Wei RG, Adler M, Davey D, Ho E, Mohan R, Polokoff M, Tseng JL, Whitlow M, Xu W, Yuan S, Phillips G..  (2007)  1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation.,  17  (9): [PMID:17368901] [10.1016/j.bmcl.2007.02.053]

Source